Linagliptin, ≥98%

Catalog No. 001811

General Information

Synonyms	BI 1356, Tradjenta, Trajenta
CAS No.	668270-12-0
M.F.	C₂₅H₂₈N₈O₂
M.W.	472.54

Technical Data

Appearance	White or off-white crystalline powder
Assay	≥98% HPLC
Solubility	DMSO
Storage	-20℃
Description	Linagliptin is a DPP-4 inhibitor developed for treatment of type II diabetes.

Reference

von Websky K, et al. Vasc Health Risk Manag. 2013;9:681-694
Haak T, et al. Int J Clin Pract. 2013 Dec;67(12):1283-93
Gallwitz B, et al. Lancet. 2012 Aug 4;380(9840):475-83
Owens DR, et al. Diabet Med. 2011 Nov;28(11):1352-61

Size	Price	Quantity	Favorites
1 g	USD198
5 g	USD545

Please inquire for non-standard packs and bulk quantities.

Availability: Ships in 1-3 days

For research use only. Not for human use.

> Certificate of Analysis

> MSDS

	(*Required Field)
*Name
*Organization Name
*Country
*Email Address
Phone
Subject	001811, Linagliptin, ≥98%, 668270-12-0
*Message
*Code

Linagliptin, ≥98%

Inquire